Fears 80% of dementia patients will MISS OUT on new blockbuster drugs partly due to poor access to NHS tests ...Middle East

The U.S. Sun - News
Fears 80% of dementia patients will MISS OUT on new blockbuster drugs partly due to poor access to NHS tests
EIGHT in 10 people at risk of dementia will miss out on blockbuster new drugs, experts warn. Many with memory trouble will not be eligible because they have the wrong type of illness or are too far gone, and poor access to NHS tests could thwart others. AlamyDementia affects about a million Brits and is the UK’s top cause of death (stock image)[/caption] Research by University College London estimated just 14 per cent of memory clinic patients could benefit. First-in-class drugs that claim to slow and even prevent Alzheimer’s disease could be approved for NHS use this year. Groundbreaking studies suggest lecanemab and donanemab are the first to ever stave off the illness, the

Hence then, the article about fears 80 of dementia patients will miss out on new blockbuster drugs partly due to poor access to nhs tests was published today ( ) and is available on The U.S. Sun ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( Fears 80% of dementia patients will MISS OUT on new blockbuster drugs partly due to poor access to NHS tests )

Apple Storegoogle play

Last updated :

Also on site :

Most viewed in News